Jason R Kelly is Director of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 3.89 Million shares of DNA, which is worth approximately $25.7 Million. The most recent transaction as insider was on Dec 12, 2022, when has been sold 98,606 shares (Class A Common Stock) at a price of $1.84 per share, resulting in proceeds of $181,435. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.89M
0% 3M change
22.02% 12M change
Total Value Held $25.7 Million

Jason R Kelly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2022
SELL
Open market or private sale
$181,435 $1.84 p/Share
98,606 Reduced 0.51%
19,415,068 Class A Common Stock
Dec 09 2022
SELL
Open market or private sale
$179,499 $1.84 p/Share
97,554 Reduced 0.5%
19,513,674 Class A Common Stock
Dec 08 2022
SELL
Open market or private sale
$173,995 $1.79 p/Share
97,204 Reduced 0.49%
19,611,228 Class A Common Stock
Dec 07 2022
SELL
Open market or private sale
$170,536 $1.69 p/Share
100,909 Reduced 0.51%
19,708,432 Class A Common Stock
Dec 06 2022
SELL
Open market or private sale
$178,868 $1.73 p/Share
103,392 Reduced 0.52%
19,809,341 Class A Common Stock
Dec 05 2022
SELL
Open market or private sale
$198,231 $1.87 p/Share
106,006 Reduced 0.53%
19,912,733 Class A Common Stock
Dec 01 2022
SELL
Open market or private sale
$197,845 $1.97 p/Share
100,429 Reduced 0.5%
20,018,739 Class A Common Stock
Nov 30 2022
SELL
Open market or private sale
$183,790 $1.79 p/Share
102,676 Reduced 0.51%
20,119,168 Class A Common Stock
Nov 29 2022
SELL
Open market or private sale
$183,222 $1.9 p/Share
96,433 Reduced 0.47%
20,221,844 Class A Common Stock
Nov 23 2022
SELL
Open market or private sale
$198,598 $1.99 p/Share
99,798 Reduced 0.49%
20,318,277 Class A Common Stock
Nov 22 2022
SELL
Open market or private sale
$207,698 $2.04 p/Share
101,813 Reduced 0.5%
20,418,075 Class A Common Stock
Nov 21 2022
SELL
Open market or private sale
$217,906 $2.1 p/Share
103,765 Reduced 0.5%
20,519,888 Class A Common Stock
Nov 18 2022
SELL
Open market or private sale
$213,879 $2.17 p/Share
98,562 Reduced 0.48%
20,623,653 Class A Common Stock
Nov 17 2022
SELL
Open market or private sale
$460,516 $2.08 p/Share
221,402 Reduced 1.06%
20,722,215 Class A Common Stock
Nov 16 2022
SELL
Open market or private sale
$530,195 $2.42 p/Share
219,089 Reduced 1.04%
20,943,617 Class A Common Stock
Nov 15 2022
SELL
Open market or private sale
$533,231 $2.51 p/Share
212,443 Reduced 0.99%
21,162,706 Class A Common Stock
Nov 14 2022
SELL
Open market or private sale
$567,481 $2.72 p/Share
208,633 Reduced 0.97%
21,375,149 Class A Common Stock
Nov 11 2022
SELL
Open market or private sale
$524,604 $2.65 p/Share
197,964 Reduced 0.91%
21,583,782 Class A Common Stock
Nov 10 2022
SELL
Open market or private sale
$457,628 $2.46 p/Share
186,028 Reduced 0.85%
21,781,746 Class A Common Stock
Nov 09 2022
SELL
Open market or private sale
$505,342 $2.43 p/Share
207,960 Reduced 0.94%
21,967,774 Class A Common Stock
Nov 08 2022
SELL
Open market or private sale
$476,295 $2.46 p/Share
193,616 Reduced 0.87%
22,175,734 Class A Common Stock
Nov 07 2022
SELL
Open market or private sale
$498,057 $2.42 p/Share
205,809 Reduced 0.91%
22,369,350 Class A Common Stock
Nov 04 2022
SELL
Open market or private sale
$514,314 $2.51 p/Share
204,906 Reduced 0.9%
22,575,159 Class A Common Stock
Nov 01 2022
SELL
Open market or private sale
$543,773 $2.77 p/Share
196,308 Reduced 0.85%
22,780,065 Class A Common Stock
Oct 31 2022
SELL
Open market or private sale
$534,327 $2.7 p/Share
197,899 Reduced 0.85%
22,976,373 Class A Common Stock
JRK

Jason R Kelly

Director
Boston, MA

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA